Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermedia...
Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease Comparative Effectiveness Research of Existing Technologies
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patien...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EVINCI-STUDY
Evaluation of Integrated Cardiac Imaging for the Detection a...
3M€
Cerrado
COMBINE-CT
Combining CT diagnostic data and interventional approaches f...
10M€
Cerrado
MPIPETrace
Clinical performance validation of a novel biomarker for qua...
4M€
Cerrado
EUIN2017-86978
DESSARROLLO DE UN BIOMARCADOR PARA LA DETECCION DE LA VULNER...
25K€
Cerrado
SMHEART
Smart Cardiac Magnetic Resonance Delivering One-Click and Co...
1M€
Cerrado
TIN2014-52923-R
DESARROLLO Y VALIDACION DE UN MODELO UNIFICADO DEL CORAZON P...
221K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patients undergoing ICA actually have obstructive CAD and ICA has relatively rare but considerable risks. Coronary computed tomography (CT) is the most accurate diagnostic test for CAD currently available. CT may become the most effective strategy to reduce the ca. 2 million annual negative ICAs in Europe by enabling early and safe discharge of the majority of patients with an intermediate risk of CAD.
To evaluate this, we propose the DISCHARGE project that will be implemented by a multinational European consortium. The core of the project is the DISCHARGE pragmatic randomised controlled trial. The primary hypothesis will be that CT is superior to ICA for major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and stroke) after a maximum follow-up of 4 years in a selected broad population of stable chest pain patients with intermediate pretest likelihood of CAD. The trial will include 25 clinical sites from 16 European countries ensuring broad geographical representation. Comparative effectiveness research of complementing work packages include gender-related analysis, systematic review of evidence, cost-effectiveness analysis, and health-related quality of life. DISCHARGE has the capability to influence current standards and guidelines as well as coverage decisions and will raise awareness among patients, health care providers, and decision-makers in Europe about the effectiveness and cost-effectiveness of coronary CT angiography.